You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Oesophageal cancer

Durvalumab with chemoradiation for untreated unresectable locally advanced oesophageal squamous cell cancer [ID6490]

  • Awaiting development
  • Reference number: GID-TA11624
  • Expected publication date: TBC
  • Project information
  • Project documents

On this page

  1. Notes
  2. Referral
  3. Referral
  4. Topic selection

Documents

Documents created during the development process.

Notes

  • Anticipate appraisal will begin during late November 2027

Referral

  • Referral

Referral

  • Referral

Topic selection

  • Topic selection

Back to top